Powered by the Consumer Technology Association (CTA)®

LAST CHANCE: Register before December 5 to save $200 on your CES 2025 registration!

Skip to content
2024 Honoree Award

Flexible Optical Biosensor Based Next-Gen Urine Analyzer

D&C Biotechnology Inc.
  • 2024 Honoree in Digital Health
CLSI categorizes urine testing as a cost-effective diagnostic method for detecting diseases efficiently compared to its cost.
However, traditional strip-based urine testing is prone to infection risks from contaminated samples and involves eight complex and inconvenient steps. Regular equipment cleaning is needed due to sample-induced contamination, and it lacks precision as it can't perform individual tests for each parameter.
To tackle these issues, we've developed our Cup Type Urine Testing KIT and incorporated a Flexible Optical Biosensor, allowing for fast and precise disease testing in a dedicated next-generation urine analyzer solution.

Learn More About Digital Health at CES

Explore the latest advancements in AI, IoT, telehealth, and digital health solutions. These groundbreaking technologies are reshaping healthcare delivery, improving patient outcomes, and enhancing operational efficiency.

Alt text: A Man with short dark hair in a white lab coat stands confidently against a vibrant, abstract background with flowing shapes in blue, purple, green and white.

See More Innovation Awards